Changing the paradigm of how IBD and other immune-mediated diseases are treated

We’re Prometheus Biosciences, an innovative biotechnology company performing groundbreaking science to discover and develop novel therapeutic and companion diagnostic product candidates for the treatment of immune-mediated diseases, starting first with inflammatory bowel disease (IBD).

Our transformational approach brings the power of big data to immune biology, changing lives through patient-centric drug design.

Our mission: to revolutionize immune-mediated medicine with precision

Our vision: to utilize targeted medicine to improve the quality of life of people with GI and immune-mediated diseases

Explore our pipeline